BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SRSF2, Q01130, 6427, SFRS2
10 results:

  • 1. RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma.
    Chang J; Zhang Y; Zhou T; Qiao Q; Shan J; Chen Y; Jiang W; Wang Y; Liu S; Wang Y; Yu Y; Li C; Li X
    J Exp Clin Cancer Res; 2024 Apr; 43(1):104. PubMed ID: 38576051
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
    Faria C; Tzankov A
    Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via srsf2-Mediated Abnormal PCLAF Splicing.
    Liu L; Lv Z; Wang M; Zhang D; Liu D; Zhu F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834680
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Momelotinib therapy for myelofibrosis: a 7-year follow-up.
    Tefferi A; Barraco D; Lasho TL; Shah S; Begna KH; Al-Kali A; Hogan WJ; Litzow MR; Hanson CA; Ketterling RP; Gangat N; Pardanani A
    Blood Cancer J; 2018 Mar; 8(3):29. PubMed ID: 29515114
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
    Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
    Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.
    Kędzierska H; Piekiełko-Witkowska A
    Cancer Lett; 2017 Jun; 396():53-65. PubMed ID: 28315432
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. srsf2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development.
    Luo C; Cheng Y; Liu Y; Chen L; Liu L; Wei N; Xie Z; Wu W; Feng Y
    Cancer Res; 2017 Mar; 77(5):1168-1178. PubMed ID: 28082404
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. srsf2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.
    Komeno Y; Huang YJ; Qiu J; Lin L; Xu Y; Zhou Y; Chen L; Monterroza DD; Li H; DeKelver RC; Yan M; Fu XD; Zhang DE
    Mol Cell Biol; 2015 Sep; 35(17):3071-82. PubMed ID: 26124281
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of srsf2 expression.
    Ma K; He Y; Zhang H; Fei Q; Niu D; Wang D; Ding X; Xu H; Chen X; Zhu J
    J Biol Chem; 2012 Feb; 287(8):5639-49. PubMed ID: 22117060
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.